Abstract:Ferroptosis is a novel form of non-apoptotic regulated cell death (RCD), with distinct characteristics and functions in physical conditions and multiple diseases such as cancers. Unlike apoptosis and autophagy, this new RCD is an iron-dependent cell death with features of lethal accumulation of reactive oxygen species (ROS) and over production of lipid peroxidation. Excessive iron from aberrant iron metabolisms or the maladjustment of the two main redox systems thiols and lipid peroxidation role as the major causes of ROS generation, and the redox-acrive ferrous (intracellular labile iron) is a crucial factor for the lipid peroxidation. Regulation of ferrroptosis also involves different pathways such as mevalonate pathway, P53 pathway and p62-Keap1-Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathway. Ferroptosis roles as a double-edged sword either suppressing or promoting tumor progression with the release of multiple signaling molecules in the tumor microenvironment. Emerging evidence suggests ferroptosis as a potential target for cancer therapy and ferroptosis inducers including small molecules and nanomaterials have been developed. The application of ferroptosis inducers also relates to overcoming drug resistance and preventing tumor metastasis, and may become a promising strategy combined with other anti-cancer therapies. Here, we summarize the ferroptosis characters from its underlying basis and role in cancer, followed by its possible applications in cancer therapies and challenges maintained.

Close interactions between lncRNAs, lipid metabolism and ferroptosis in cancer

Iron Metabolism, Ferroptosis, and Lncrna in Cancer: Knowns and Unknowns

Targeting Ferroptosis in Breast Cancer

Ferroptosis and hepatocellular carcinoma: the emerging role of lncRNAs

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

The role of non-coding RNAs in ferroptosis regulation

The interaction between ferroptosis and lipid metabolism in cancer

Advances in understanding the role of lncRNA in ferroptosis

Ferroptosis in Cancer Progression: Role of Noncoding RNAs

Long noncoding RNAs induced control of ferroptosis: Implications in cancer progression and treatment

Noncoding RNAs in cancer ferroptosis: From biology to clinical opportunity

Long non-coding RNAs in ferroptosis, pyroptosis and necroptosis: from functions to clinical implications in cancer therapy

Metabolism-regulated ferroptosis in cancer progression and therapy

Regulation of ferroptosis by ncRNA : A new direction

Molecular mechanism of cell ferroptosis and research progress in regulation of ferroptosis by noncoding RNAs in tumor cells

Role of ferroptosis and ferroptosis-related long non'coding RNA in breast cancer

The function and mechanism of ferroptosis in cancer

Regulating ferroptosis by non-coding RNAs in hepatocellular carcinoma

Ferroptosis Holds Novel Promise in Treatment of Cancer Mediated by Non-coding RNAs

Lipid metabolism in ferroptosis and ferroptosis-based cancer therapy

Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy